![Colleen Cuffaro](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Colleen Cuffaro
Algemeen Directeur bij
RADD Pharmaceuticals, Inc.
Profiel
Colleen Cuffaro currently works at RADD Pharmaceuticals, Inc., as President & Chief Executive Officer, New England Venture Capital Association, Inc., as Director, Arrakis Therapeutics, Inc., as Director, Comet Therapeutics, Inc., as Director, and Canaan Management, Inc., as Partner from 2020.
Dr. Cuffaro received her undergraduate degree from the University of Pennsylvania and graduate degree from Yale University.
Actieve functies van Colleen Cuffaro
| Bedrijven | Functie | Begin |
|---|---|---|
Canaan Management, Inc.
 Canaan Management, Inc. Investment ManagersFinance Canaan Management invests in companies located in the United States. The firm focuses on companies such as consumer, fintech, enterprise/cloud, biopharmaceuticals, medical technology and digital health. It participates in early-stage capital requirements. | Private Equity Analist | 01-01-2014 |
Arrakis Therapeutics, Inc.
 Arrakis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops RNA-targeted small molecules on neurologic diseases, cancer and rare genetic diseases | Directeur/Bestuurslid | - |
New England Venture Capital Association, Inc.
 New England Venture Capital Association, Inc. Miscellaneous Commercial ServicesCommercial Services Operates trade association that encourages constructive interaction among the region's venture firms by promoting camaraderie among its members | Directeur/Bestuurslid | - |
Comet Therapeutics, Inc.
 Comet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes treatments for patients suffering from metabolic, neurological and immunological disorders | Directeur/Bestuurslid | - |
RADD Pharmaceuticals, Inc.
 RADD Pharmaceuticals, Inc. Pharmaceuticals: GenericHealth Technology Develops novel platform designed to address mechano-enzyme drug discovery and development | Algemeen Directeur | - |
Opleiding van Colleen Cuffaro
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
24
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Canaan Management, Inc.
Canaan Management, Inc. Investment ManagersFinance Canaan Management invests in companies located in the United States. The firm focuses on companies such as consumer, fintech, enterprise/cloud, biopharmaceuticals, medical technology and digital health. It participates in early-stage capital requirements. | Finance |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New England Venture Capital Association, Inc.
New England Venture Capital Association, Inc. Miscellaneous Commercial ServicesCommercial Services Operates trade association that encourages constructive interaction among the region's venture firms by promoting camaraderie among its members | Commercial Services |
Arrakis Therapeutics, Inc.
Arrakis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops RNA-targeted small molecules on neurologic diseases, cancer and rare genetic diseases | Health Technology |
Comet Therapeutics, Inc.
Comet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes treatments for patients suffering from metabolic, neurological and immunological disorders | Health Technology |
RADD Pharmaceuticals, Inc.
RADD Pharmaceuticals, Inc. Pharmaceuticals: GenericHealth Technology Develops novel platform designed to address mechano-enzyme drug discovery and development | Health Technology |
